Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes.


Journal

Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438

Informations de publication

Date de publication:
30 11 2021
Historique:
received: 05 04 2021
accepted: 17 10 2021
entrez: 1 12 2021
pubmed: 2 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

We performed expression quantitative trait locus (eQTL) analysis in single classical (CL) and non-classical (NCL) monocytes from patients with systemic lupus erythematosus (SLE) to quantify the impact of well-established genetic risk alleles on transcription at single-cell resolution. Single-cell gene expression was quantified using qPCR in purified monocyte subpopulations (CD14 The SLE-risk alleles demonstrated significantly more eQTLs in NCLs as compared to CLs (p = 0.0004). There were 18 eQTLs exclusive to NCL cells, 5 eQTLs exclusive to CL cells, and only one shared eQTL, supporting large differences in the impact of the risk alleles between these monocyte subsets. The SPP1 and TNFAIP3 loci were associated with the greatest number of transcripts. Patterns of shared influence in which different SNPs impacted the same transcript also differed between monocyte subsets, with greater evidence for synergy in NCL cells. IRF1 expression demonstrated an on/off pattern, in which expression was zero in all of the monocytes studied from some individuals, and this pattern was associated with a number of SLE risk alleles. We observed corroborating evidence of this IRF1 expression pattern in public data sets. We document multiple SLE-risk allele eQTLs in single monocytes which differ greatly between CL and NCL subsets. These data support the importance of the SPP1 and TNFAIP3 risk variants and the IRF1 transcript in SLE patient monocyte function.

Sections du résumé

BACKGROUND
We performed expression quantitative trait locus (eQTL) analysis in single classical (CL) and non-classical (NCL) monocytes from patients with systemic lupus erythematosus (SLE) to quantify the impact of well-established genetic risk alleles on transcription at single-cell resolution.
METHODS
Single-cell gene expression was quantified using qPCR in purified monocyte subpopulations (CD14
RESULTS
The SLE-risk alleles demonstrated significantly more eQTLs in NCLs as compared to CLs (p = 0.0004). There were 18 eQTLs exclusive to NCL cells, 5 eQTLs exclusive to CL cells, and only one shared eQTL, supporting large differences in the impact of the risk alleles between these monocyte subsets. The SPP1 and TNFAIP3 loci were associated with the greatest number of transcripts. Patterns of shared influence in which different SNPs impacted the same transcript also differed between monocyte subsets, with greater evidence for synergy in NCL cells. IRF1 expression demonstrated an on/off pattern, in which expression was zero in all of the monocytes studied from some individuals, and this pattern was associated with a number of SLE risk alleles. We observed corroborating evidence of this IRF1 expression pattern in public data sets.
CONCLUSIONS
We document multiple SLE-risk allele eQTLs in single monocytes which differ greatly between CL and NCL subsets. These data support the importance of the SPP1 and TNFAIP3 risk variants and the IRF1 transcript in SLE patient monocyte function.

Identifiants

pubmed: 34847931
doi: 10.1186/s13075-021-02660-2
pii: 10.1186/s13075-021-02660-2
pmc: PMC8630910
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

290

Subventions

Organisme : NIH HHS
ID : AR060861, AR057781, AR065964, AI071651
Pays : United States
Organisme : U.S. Army
ID : W81XWH-20-1-0686

Informations de copyright

© 2021. The Author(s).

Références

Nat Commun. 2021 Feb 2;12(1):738
pubmed: 33531494
Nat Cancer. 2020 May;1(5):493-506
pubmed: 33409501
J Clin Invest. 2017 Apr 3;127(4):1271-1283
pubmed: 28263189
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
BMC Genomics. 2021 May 1;22(1):319
pubmed: 33932993
J Autoimmun. 2015 Jun;60:51-58
pubmed: 25921064
Methods. 2013 Jan;59(1):71-9
pubmed: 23079396
Am J Hum Genet. 2020 Nov 5;107(5):864-881
pubmed: 33031749
J Autoimmun. 2015 Nov;64:125-36
pubmed: 26324017
Nat Commun. 2017 Jul 17;8:16021
pubmed: 28714469
Nat Biotechnol. 2013 Aug;31(8):748-52
pubmed: 23873083
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1896-901
pubmed: 12578971
J Autoimmun. 2020 Jun;110:102359
pubmed: 31806421
Front Immunol. 2020 Jul 16;11:1384
pubmed: 32765497
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Nat Genet. 2011 Mar;43(3):253-8
pubmed: 21336280
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5724-9
pubmed: 21422297
Lupus Sci Med. 2017 Jun 25;4(1):e000202
pubmed: 29238602
Genes Immun. 2009 Jul;10(5):487-94
pubmed: 19339987

Auteurs

Yogita Ghodke-Puranik (Y)

Colton Center for Autoimmunity, NYU Grossman School of Medicine, 550 1st Ave, New York, NY, 10016, USA.

Zhongbo Jin (Z)

Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.

Kip D Zimmerman (KD)

Department of Biostatistics and Data Science and Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Hannah C Ainsworth (HC)

Department of Biostatistics and Data Science and Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Wei Fan (W)

Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Mark A Jensen (MA)

Colton Center for Autoimmunity, NYU Grossman School of Medicine, 550 1st Ave, New York, NY, 10016, USA.

Jessica M Dorschner (JM)

Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Danielle M Vsetecka (DM)

Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Shreyasee Amin (S)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Ashima Makol (A)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Floranne Ernste (F)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Thomas Osborn (T)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Kevin Moder (K)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Vaidehi Chowdhary (V)

Division of Rheumatology, Allergy and Immunology, Yale University School of Medicine, New Haven, USA.

Carl D Langefeld (CD)

Department of Biostatistics and Data Science and Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Timothy B Niewold (TB)

Colton Center for Autoimmunity, NYU Grossman School of Medicine, 550 1st Ave, New York, NY, 10016, USA. Timothy.Niewold@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH